Streetbeat News

Stock Prices

UNP

Benchmark analyst Nathan Martin has reiterated a Buy rating on Union Pacific (NYSE:UNP) and maintained a $260 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 5:34 pm

TMUS

Benchmark analyst Matthew Harrigan has reiterated a Buy rating on T-Mobile US (NASDAQ:TMUS) and maintained a $200 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 5:32 pm

AMSC

AREB

BAH

CAPT

GRFX

IPDN

NVVE

SAVE

VLD

In Friday's intraday session, several industrial stocks experienced significant movements. Velo3D (VLD) saw an 18.4% increase, while Booz Allen Hamilton (BAH) rose by 12.32% following their Q3 earnings release. Captivision (CAPT) and American Superconductor (AMSC) also gained, with AMSC's Q3 earnings released two days prior. Conversely, Richtech Robotics (RR) plummeted by 69.7%, Nuvve Holding (NVVE) dropped 30.73%, Graphex Group (GRFX), Professional Diversity (IPDN), American Rebel Holdings (AREB), and Spirit Airlines (SAVE) all saw declines in their stock prices.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:31 pm

BFX

EVTV

GCT

GMBL

GNS

GSUN

LANV

SLNA

TKLF

VLCN

VNCE

ZCMD

During Friday's intraday session, several consumer discretionary stocks experienced significant movements. Selina Hospitality (SLNA) saw a 24.9% increase, while Envirotech Vehicles (EVTV) rose by 20.83%. Vince Holding (VNCE) and Esports Entertainment (GMBL) also saw gains of 16.18% and 16.09%, respectively. BowFlex (BFX) and GigaCloud Tech (GCT) shares rose as well. Conversely, Yoshitsu Co (TKLF) plummeted by 60%, and other stocks such as Lanvin Group Hldgs (LANV), Genius Gr (GNS), Golden Sun Education Gr (GSUN), Volcon (VLCN), and ZHONGCHAO (ZCMD) experienced declines.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:31 pm

ACON

CRBP

ONCO

ZJYL

In Friday's intraday session, several healthcare stocks experienced significant movements. Corbus Pharmaceuticals (CRBP) saw a massive increase of 309.1%, while Aclarion (ACON) rose by 67.82%. Inspire Veterinary (IVP), Panbela Therapeutics (PBLA), Inhibikase Therapeutics (IKT), and Vera Therapeutics (VERA) also posted gains. Conversely, Onconetix (ONCO), Processa Pharma (PCSA), Evaxion Biotech (EVAX), Jin Medical International (ZJYL), Acutus Medical (AFIB), and TC BioPharm (TCBP) experienced declines, with ONCO leading the losses at 33.7%.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:31 pm

APPF

CIFR

CYN

DAVE

GSIT

INTC

MIGI

MOB

OST

QUIK

SLNHP

SNCR

In Friday's intraday session, several IT stocks experienced significant movements. AppFolio's stock surged 28.3% after their Q4 earnings report. Mawson Infra Gr, Synchronoss Technologies, Cipher Mining, and Cyngn also saw gains. Conversely, Mobilicom, Ostin Technology Group, Dave, GSI Technology, QuickLogic, and Intel reported losses, with Intel's drop following their Q4 earnings release.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:31 pm

INTC

Benchmark analyst Cody Acree has maintained a Buy rating on Intel Corporation (NASDAQ:INTC) and increased the price target from $52 to $62.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 5:30 pm

ALPN

Alpine Immune Sciences' stock (ALPN) is trading higher following an Outperform rating confirmation and a price target increase from $26 to $35 by Wedbush.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 5:28 pm

AVBP

ArriVent BioPharma's stock is indicating a price of $24.00 based on a volume of 321,953 shares traded.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 5:28 pm

FISI

Shares of Financial Institutions, Inc. (FISI) are trading lower following the release of their fourth-quarter financial results, which fell short of market expectations.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 5:27 pm